The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 26, 2022
Filed:
Dec. 29, 2015
Applicant:
Baylor College of Medicine, Houston, TX (US);
Inventors:
David Michael Lonard, Pearland, TX (US);
Lei Wang, Pearland, TX (US);
Bert W. O'Malley, Houston, TX (US);
Jianming Xu, Bellaire, TX (US);
Yongcheng Song, Pearland, TX (US);
Xiaonan Li, Sugar Land, TX (US);
Timothy Gerald Palzkill, Houston, TX (US);
Assignee:
BAYLOR COLLEGE OF MEDICINE, Houston, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 49/753 (2006.01); A61K 31/444 (2006.01); A61K 31/45 (2006.01); A61K 31/4402 (2006.01); A61K 31/351 (2006.01); A61K 31/4433 (2006.01); A61K 31/122 (2006.01); A61K 31/4545 (2006.01); C07D 401/06 (2006.01); C07D 309/38 (2006.01); C07D 405/06 (2006.01); C07D 213/68 (2006.01); C07D 405/12 (2006.01); A61P 35/00 (2006.01); C07C 49/697 (2006.01); C07D 211/86 (2006.01); C07D 213/50 (2006.01); C07D 309/32 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07C 49/753 (2013.01); A61K 31/122 (2013.01); A61K 31/351 (2013.01); A61K 31/4402 (2013.01); A61K 31/444 (2013.01); A61K 31/4433 (2013.01); A61K 31/45 (2013.01); A61K 31/4545 (2013.01); A61P 35/00 (2018.01); C07C 49/697 (2013.01); C07D 211/86 (2013.01); C07D 213/50 (2013.01); C07D 213/68 (2013.01); C07D 309/32 (2013.01); C07D 309/38 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07C 2601/14 (2017.05);
Abstract
Small molecule stimulators of steroid receptor coactivator (SRC) family proteins are provided, as well as methods for their use in treating or preventing cancer. Also provided are methods for stimulating SRC family proteins in a cell.